Moloney Securities Asset Management LLC raised its holdings in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 53.8% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,732 shares of the company's stock after acquiring an additional 14,245 shares during the quarter. Moloney Securities Asset Management LLC's holdings in Roche were worth $1,672,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently bought and sold shares of RHHBY. HighPoint Advisor Group LLC grew its position in shares of Roche by 2.8% during the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after buying an additional 304 shares in the last quarter. Hancock Whitney Corp lifted its stake in shares of Roche by 6.8% during the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after purchasing an additional 1,496 shares during the last quarter. Minot DeBlois Advisors LLC purchased a new stake in shares of Roche during the 4th quarter worth $752,000. Confluence Investment Management LLC lifted its stake in shares of Roche by 3.6% during the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after purchasing an additional 510 shares during the last quarter. Finally, Boston Common Asset Management LLC lifted its stake in shares of Roche by 10.0% during the 1st quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock worth $13,369,000 after purchasing an additional 29,522 shares during the last quarter.
Roche Price Performance
Roche stock traded down $0.73 during mid-day trading on Friday, hitting $40.49. 1,941,801 shares of the company were exchanged, compared to its average volume of 1,088,582. Roche Holding AG has a 12-month low of $34.10 and a 12-month high of $44.31. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.48. The business's 50 day simple moving average is $40.12 and its two-hundred day simple moving average is $39.70.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on RHHBY shares. Hsbc Global Res cut Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 28th. HSBC downgraded Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy".
Check Out Our Latest Stock Analysis on Roche
About Roche
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Stories
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
